New concepts in breast cancer metastasis: Tumor initiating cells and the microenvironment

Clinical and Experimental Metastasis

Volumn 24, Issue 8, 2007, Pages 707-715

  Sleeman, Jonathan P ^a   Cremers, Natascha ^b  

^a UNIVERSITY OF KARLSRUHE   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Cancer stem cells; Clonal heterogeneity; Epigenetic reprogramming; Epithelial mesenchymal transition; Pre metastatic niche

Indexed keywords

BREAST CANCER; CANCER STEM CELL; CARCINOGENESIS; CELL POPULATION; CELL SUBPOPULATION; HUMAN; METASTASIS; MICROENVIRONMENT; NONHUMAN; REVIEW; TUMOR CELL; TUMOR GROWTH;

BREAST NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS;

EID: 36349025372     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9122-6     Document Type: Review

References (88)

1. Sleeman JP (2000) The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157:55-81
2. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12:89-96
3. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458
4. Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418:823
5. van't Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
6. van de Vijver MJ, He YD, van't Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
7. Weigelt B, Glas AM, Wessels LF et al (2003) Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 100:15901-15905
8. Weigelt B, Hu Z, He X et al (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 65:9155-9158
9. Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537-549
10. Minn AJ, Kang Y, Serganova I et al (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44-55
11. Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518-524
12. Kang Y, He W, Tulley S et al (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci USA 102:13909-13914
13. Deckers M, van Dinther M, Buijs J et al (2006) The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66:2202-2209
14. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142
15. Berx GER, Christofori G et al (2007) Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis
16. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267-284
17. Kelly PN, Dakic A, Adams JM et al (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317:337
18. Kruger JA, Kaplan CD, Luo Y et al (2006) Characterization of stem cell-like cancer cells in immune-competent mice. Blood 108:3906-3912
19. Ghods AJ, Irvin D, Liu G et al (2007) Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25:1645-1653
20. Li Y, Welm B, Podsypanina K et al (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100:15853-15858
21. Roy M, Pear WS, Aster JC (2007) The multifaceted role of Notch in cancer. Curr Opin Genet Dev 17:52-59
22. Clement V, Sanchez P, de Tribolet N et al (2007) HEDGEHOG-GLI1 Signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17:165-172
23. Piccirillo SG, Reynolds BA, Zanetti N et al (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444:761-765
24. Burkert J, Wright NA, Alison MR (2006) Stem cells and cancer: an intimate relationship. J Pathol 209:287-297
25. Li F, Tiede B, Massague J et al (2007) Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 17:3-14
26. Al-Hajj M, Becker MW, Wicha M et al (2004) Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14:43-47
27. + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777-1785
28. -/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11:1154-1159
29. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988
30. Ponti D, Costa A, Zaffaroni N et al (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506-5511
31. Shipitsin M, Campbell LL, Argani P et al (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11:259-273
32. Brabletz T, Jung A, Spaderna S et al (2005) Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 5:744-749
33. Lugo TG, Braun S, Cote RJ et al (2003) Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol 21:2609-2615
34. Balic M, Lin H, Young L et al (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12:5615-5621
35. Sheridan C, Kishimoto H, Fuchs RK et al (2006) CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8:R59
36. Liu R, Wang X, Chen GY et al (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217-226
37. Gotte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66:10233-10237
38. Lopez JI, Camenisch TD, Stevens MV et al (2005) CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 65:6755-6763
39. Kaufmann M, Heider KH, Sinn HP et al (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345:615-619
40. Sinn HP, Heider KH, Skroch-Angel P et al (1995) Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res Treat 36:307-313
41. Tempfer C, Losch A, Heinzl H et al (1996) Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 32A:2023-2025
42. Jansen RH, Joosten-Achjanie SR, Arends JW et al (1998) CD44v6 is not a prognostic factor in primary breast cancer. Ann Oncol 9:109-111
43. Tokue Y, Matsumura Y, Katsumata N et al (1998) CD44 variant isoform expression and breast cancer prognosis. Jpn J Cancer Res 89:283-290
44. Friedrichs K, Franke F, Lisboa BW et al (1995) CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55:5424-5433
45. Foekens JA, Dall P, Klijn JG et al (1999) Prognostic value of CD44 variant expression in primary breast cancer. Int J Cancer 84:209-215
46. Watanabe O, Kinoshita J, Shimizu T et al (2005) Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer. J Exp Clin Cancer Res 24:75-82
47. Kristiansen G, Winzer KJ, Mayordomo E et al (2003) CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9:4906-4913
48. Kristiansen G, Schluns K, Yongwei Y et al (2003) CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer 88:231-236
49. Kristiansen G, Denkert C, Schluns K et al (2002) CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 161:1215-1221
50. Kristiansen G, Pilarsky C, Pervan J et al (2004) CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58:183-192
51. Yang GP, Ross DT, Kuang WW et al (1999) Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res 27:1517-1523
52. Nestl A, Von Stein OD, Zatloukal K et al (2001) Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 61:1569-1577
53. Dupont VN, Gentien D, Oberkampf M et al (2007) A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients. Int J Cancer 121:1036-1046
54. Aigner S, Ramos CL, Hafezi-Moghadam A et al (1998) CD24 mediates rolling of breast carcinoma cells on P-selectin. Faseb J 12:1241-1251
55. Schabath H, Runz S, Joumaa S et al (2006) CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 119:314-325
56. Baumann P, Cremers N, Kroese F et al (2005) CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 65:10783-10793
57. Brawley C, Matunis E (2004) Regeneration of male germline stem cells by spermatogonial dedifferentiation in vivo. Science 304:1331-1334
58. Nakagawa T, Nabeshima Y, Yoshida S (2007) Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. Dev Cell 12:195-206
59. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317
60. Wernig M, Meissner A, Foreman R et al (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324
61. Maherali N, Sridharan R, Xie W et al (2007) Directly reprogrammed fibroblasts show global epigenetic remodelling and widespread tissue contribution. Cell Stem Cell 1:55-70
62. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1: 571-573
63. Kaplan RN, Rafii S, Lyden D (2006) Preparing the "soil": the premetastatic niche. Cancer Res 66:11089-11093
64. Kaplan RN, Riba RD, Zacharoulis S et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827
65. Hiratsuka S, Watanabe A, Aburatani H et al (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8:1369-1375
66. Hiratsuka S, Nakamura K, Iwai S et al (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289-300
67. Hirakawa S, Kodama S, Kunstfeld R et al (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089-1099
68. Qian CN, Berghuis B, Tsarfaty G et al (2006) Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res 66:10365-10376
69. Hirakawa S, Brown LF, Kodama S et al (2006) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010-1017
70. Eccles S, Paon L, Sleeman JP (2007) Lymphatic metastasis: importance and new insights into cellular and molecular mechanisms. Clin Exp Metastasis
71. Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells Cancer Cell 11:69-82
72. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl): 245-254
73. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683-692
74. Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107-116
75. Eden A, Gaudet F, Waghmare A et al (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455
76. Fraga MF, Ballestar E, Villar-Garea A et al (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37:391-400
77. Hendrix MJ, Seftor EA, Seftor RE et al (2007) Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7:246-255
78. Widschwendter M, Fiegl H, Egle D et al (2007) Epigenetic stem cell signature in cancer. Nat Genet 39:157-158
79. Sparmann A, van Lohuizen M (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6:846-856
80. Liu S, Dontu G, Mantle ID et al (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071
81. Prince ME, Sivanandan R, Kaczorowski A et al (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104:973-978
82. Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-260
83. Cui H, Ma J, Ding J et al (2006) Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration- dependent manner. J Biol Chem 281:34696-34704
84. Mishra L, Shetty K, Tang Y et al (2005) The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24:5775-5789
85. Polyak K, Hu M (2005) Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia 10:231-247
86. Prindull G (2005) Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells? Exp Hematol 33:738-746
87. Ein-Dor L, Kela I, Getz G et al (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21:171-178
88. Fan C, Oh DS, Wessels L et al (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560-569